The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2017

Filed:

May. 13, 2016
Applicant:

Immunomet Therapeutics, Inc., Houston, TX (US);

Inventors:

Seok Gu Kang, Suwon-si, KR;

Ji Hyun Lee, Goyang-si, KR;

Jong Hee Chang, Seoul, KR;

Jae Ho Cheong, Seoul, KR;

Jun Jeong Choi, Incheon, KR;

Sung Wuk Kim, Seongnam-si, KR;

Sang Hee Yoo, Daejeon, KR;

Hong Woo Kim, Daejeon, KR;

Soon Im Lee, Seoul, KR;

Assignee:

IMMUNOMET THERAPEUTICS, INC, Houston, TX (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/52 (2006.01); A61K 31/40 (2006.01); A61K 31/495 (2006.01);
U.S. Cl.
CPC ...
A61K 31/40 (2013.01); A61K 31/495 (2013.01);
Abstract

The present invention provides novel uses of a biguanide derivative for preventing or treating glioblastoma. The compound of Formula 1 and its pharmaceutically acceptable salts can be used for preventing and treating glioblastoma. Further, the combined treatment of the compound of Formula 1 and temozolomide can provide superior effects compared to the administration of the compound of Formula 1 alone or temozolomide alone.


Find Patent Forward Citations

Loading…